Screening for cancer: when to stop?: A practical guide and review of the evidence.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25700582.
- Also identified by DOI 10.1016/j.mcna.2014.11.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Deciding when to stop cancer screening in older adults is a complex challenge that involves multiple factors: individual health status and life expectancy; risks and benefits of screening, which vary with age and comorbidity; and individual preferences and values. This article examines current cancer screening practices and reviews the risks and benefits of cancer screening for colorectal, breast, lung, prostate, and cervical cancer, particularly in older individuals and those with multiple comorbidities. Tools for estimating life expectancy are reviewed, and a practical framework is presented to guide discussions on when the harms of screening likely outweigh the benefits.
Medical subject headings
- Mass Screening
- Neoplasms
- Practice Guidelines as Topic